Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Building a Chemical Toolbox for Human Pregnane X Receptor Research: Discovery of Agonists, Inverse Agonists, and Antagonists Among Analogs Based on the Unique Chemical Scaffold of SPA70. | J Med Chem | 2021 | 33497575 | PubTator, text mining | PubMed |
| Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications. | Obesity (Silver Spring) | 2021 | 33491309 | PubTator, text mining | PubMed |
| IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes. | Acta Derm Venereol | 2021 | 33491092 | PubTator, text mining | PubMed |
| Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters. | Xenobiotica | 2021 | 33455503 | PubTator, text mining | PubMed |
| Evaluation of the CYP3A and CYP2B6 Drug-Drug Interaction Potential of Lemborexant. | Clin Pharmacol Drug Dev | 2021 | 33455055 | PubTator, text mining | PubMed |
| Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations. | Int J Mol Sci | 2021 | 33450934 | PubTator, text mining | PubMed |
| Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases. | Cell Mol Life Sci | 2021 | 33449144 | PubTator, text mining | PubMed |
| Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms. | Int J Mol Sci | 2021 | 33440869 | PubTator, text mining | PubMed |
| Generation of proliferating human adult hepatocytes using optimized 3D culture conditions. | Sci Rep | 2021 | 33436872 | PubTator, text mining | PubMed |
| Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid. | Pharmaceutics | 2021 | 33435470 | PubTator, text mining | PubMed |
| Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins. | Br J Pharmacol | 2021 | 33434947 | PubTator, text mining | PubMed |
| Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. | Pharmaceuticals (Basel) | 2021 | 33429918 | PubTator, text mining | PubMed |
| Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections. | Cell Death Dis | 2021 | 33414457 | PubTator, text mining | PubMed |
| Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. | Biomed Pharmacother | 2021 | 33378980 | PubTator, text mining | PubMed |
| Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers. | Clin Pharmacol Drug Dev | 2021 | 33378139 | PubTator, text mining | PubMed |
| Inducible plasmid display system for high-throughput selection of proteins with improved solubility. | J Biotechnol | 2021 | 33373627 | PubTator, text mining | PubMed |
| Metformin, chronic nephropathy and lactic acidosis: a multi-faceted issue for the nephrologist. | J Nephrol | 2021 | 33373028 | PubTator, text mining | PubMed |
| Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy. | Expert Opin Drug Metab Toxicol | 2021 | 33339463 | PubTator, text mining | PubMed |
| Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits. | Pharmacol Ther | 2021 | 33310157 | PubTator, text mining | PubMed |
| Inhibitory effects of vandetanib on creatinine transport via renal organic cation transporter OCT2. | Eur J Pharm Sci | 2021 | 33296710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=53